Canonical text (the exact bytes fingerprinted)

TRUVACE RECORD VERSION
record: TRV-2026-1256
version: 1
kind: certified
reason: Certified into the record
timestamp: 2026-10-03T06:55:09.956695Z
status: published
lens: g_space
sector: health
headline: Multiclass Diagnostic Improvement of Interstitial Cystitis (IC) and Overactive Bladder (OAB) via Machine Learning Pipeline on Surface-Enhanced Raman Spectroscopy (SERS)
dek: Interstitial cystitis (IC) and overactive bladder (OAB) are chronic pelvic conditions with shared symptoms of urinary urgency, increased frequency, and nocturia with pain in the bladder. IC is characterized by bladder pain and inflammation without a clear etiology, whereas OAB involves detrusor overactivity in the absence of infection. Despite this symptomatic overlap, IC and OAB differ in underlying pathophysiology and require distinct treatment and medical care. A specific diagnostic strategy is currently lack…
gain_title: A machine learning pipeline applied to urine SERS spectra improved multiclass diagnosis of IC and OAB versus healthy controls, achieving up to 92% accuracy with interpretable pathologic Raman features.
problem_title: (none)
trace_subject: (none)
gain_reading: A machine learning pipeline applied to urine SERS spectra improved multiclass diagnosis of IC and OAB versus healthy controls, achieving up to 92% accuracy with interpretable pathologic Raman features.
gain_evidence: reached up to 92% accuracy with interpretable and pathologic relative Raman features for discriminating among healthy control, IC, and OAB | urinary samples were collected from healthy individuals (n = 117), IC patients (n = 19), and OAB patients (n = 45) for the acquisition of Raman spectra using Au-ZnO nanorod surface-enhanced Raman spectroscopy (SERS) chips | urine-based SERS Raman spectra combined with machine learning could serve as a promising diagnostic platform to support disease-specific clinical decision
problem_reading: (none)
problem_evidence: (none)
quick_read: On October 2, 2026, a peer-reviewed study in ACS Sensors reported a urine-based diagnostic pipeline for interstitial cystitis and overactive bladder. Samples from 117 healthy controls, 19 IC patients, and 45 OAB patients were analyzed with Au-ZnO nanorod SERS chips, and spectra were classified using PCA-PLS-DA, PCA-LDA, XGBoost, and LightGBM, reaching up to 92% accuracy for three-way discrimination.

The result matters because IC and OAB share urgency, frequency, and bladder pain but require distinct care, and current diagnosis often relies on exclusion. A noninvasive, interpretable spectral classifier could enable disease-specific decisions, though the reported accuracy is from a small, single-cohort study and remains a promising platform rather than a validated clinical test.
limitation: 
tag: Evidence-backed gain
key_points: Study collected urine from 117 healthy controls, 19 IC patients, and 45 OAB patients for SERS acquisition. | Raman spectra were acquired using Au-ZnO nanorod surface-enhanced Raman spectroscopy chips. | Linear models PCA-PLS-DA and PCA-LDA and nonlinear models XGBoost and LightGBM were tested. | Best models reached up to 92% accuracy for three-way classification with biologically interpretable features.
rundown: Researchers collected urine from 117 healthy individuals, 19 IC patients, and 45 OAB patients and measured molecular fingerprints using Au-ZnO nanorod SERS chips. The work addresses the lack of a specific diagnostic strategy for two conditions that share urgency, frequency, and nocturia but differ in pathophysiology and treatment.

Four classifiers were evaluated: PCA-PLS-DA and PCA-LDA as linear models and XGBoost and LightGBM as tree-based nonlinear models. The pipeline aimed to obtain biologically interpretable Raman spectra per group while maximizing classification performance.

The models discriminated among healthy control, IC, and OAB with up to 92% accuracy and yielded interpretable and pathologic relative Raman features. Authors frame urine-based SERS combined with machine learning as a promising platform to support disease-specific clinical decisions rather than exclusion-based diagnosis.
sources:
- peer_reviewed | ACS Sensors | https://doi.org/10.1021/acssensors.6c02725 | 2026-10-02
prev: 0000000000000000000000000000000000000000000000000000000000000000

sha256

2f246653562a257eb7aa4df7315e879a60361f2cb42f48d8fcb52f9c3a85cd1b

previous

0000000000000000000000000000000000000000000000000000000000000000